Our findings indicate a mechanistic model for the regulation of PRP3 by TXNL4B and the regulation of FANCI splicing isoforms by PRP3 in lung cancer that may have consequences for the susceptibility of this cancer type to radiotherapy (Figure 8D). This evidence concerns the gene TXNL4B and lung cancer.